Perioperative antiarrhythmische Therapie

Zusammenfassung.

Perioperative Arrhythmien werden häufig beobachtet. Bei immerhin 2,5 % aller perioperativen Patienten stellen sie eine ernstzunehmende Komplikation dar. In dieser Übersicht wird zunächst das myokardiale Reizbildungs- und Reizleitungssystem erklärt, dann die spezielle Ätiologie und Pathophysiologie wichtiger perioperativer Arrhythmien diskutiert, bevor auf ausgewählte Antiarrhythmika genauer eingegangen wird. Schließlich werden Therapievorschläge für die häufigsten Arrhythmien vorgestellt.

Perioperative Antiarrhythmic Drug Management.

Perioperative arrhythmias are common. In 2.5 % they result in a severe adverse outcome. This review discusses the normal physiology of the myocardial conduction system and the etiology and pathophysiology of the most common perioperative dysrhythmias. Subsequently some important antiarrhythmic drugs are described and treatment plans for the most frequent dysrhythmias are presented.

Schlüsselwörter:

Perioperative Arrhythmien - Antiarrhythmikaeinsatz

Key words:

Perioperative dysrhythmias - Antiaarrhythmic drug management

Literatur

• 1 Forrest J, Cahalan M, Rehder K, Goldsmith C, Levy R, Strunin L, Bota W, Bouchek C, Bucchiara R, Dhamee M, Domino K, Dudman A, Hamilton W, Kampine J, Kotrly K, Maltby J, Mazloomdoost M, MacKenzie R, Melnick B, Motoyama E, Muir J, Munshi C. Multicenter study of general anesthesia. II. Results.  Anesthesiology. 1990;  72 262-268
• 2 O'Kelly B, Browner W S, Massie B, Tubau J, Ngo L, Mangano D T. Ventricular arrhythmias in patients undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group.  J Am Med Ass. 1992;  268 217-221
• 3 Bertrand C A, Steiner N V, Jameson A G. Disturbances of cardiac rhythm during anesthesia and surgery.  J Am Med Ass. 1971;  216 1615-1617
• 4 Mahle E, Rotman B, Rehak P, Atlee J L, Gombotz H, Berger J, List W F, Klein W, Metzler S. Perioperative ventricular dysrhythmias in patients with structural heart disease undergoing noncardiac surgery.  Anesth Analg. 1998;  86 16-21
• 5 Atlee J L, Bosnjak Z J. Mechanisms for cardiac arrhythmias during anesthesia.  Anesthesiology. 1990;  72 347-374
• 6 Bosnjak Z J, Kampine J T. Effects of halothane, enflurane, and isoflurane on the SA node.  Anesthesiology. 1983;  S8 314
• 7 Johnston R R, Eger E I, Wilson C. A comparative interaction of epinephrine with enflurane, isoflurane and halothane in man.  Anesth Analg. 1976;  55 709-712
• 8 Moore M, Weiskopf R, Eger E I. Arrhythmogenic doses of epinephrine are similar during desflurane for isoflurane anesthesia in humans.  Anesthesiology. 1993;  79 943-947
• 9 Navarro R, Weiskopf R B, Moore M A. Humans anesthesized with sevoflurane or isoflurane have similar arrhythmic response to epinephrine.  Anesthesiology. 1994;  80 545-549
• 10 Koehntop D E, Liao J C, Van Bergen F H. Effects of pharmacologic alterations of adrenergic mechanisms by cocaine, tropolone, aminophylline, and ketamine on epinephrine-induced arrhythmias during halothan-nitrous oxide anesthesia.  Anesthesiology. 1997;  46 83-93
• 11 Dimich I, Lingham R, Narang J. Esmolol prevents and suppresses arrhythmias during halothane anesthesia in dogs.  Can J Anest. 1992;  39 83-86
• 12 Yasuda I, Hirano T, Ahama K, Fudeta H, Obara S. Chronotropic effect of succinylcholine and succinylmonocholine on the sinuatrial node.  Anesthesiology. 1982;  57 289-292
• 13 Jacobs H K, Lim S, Salem M R, Rao T LK, Mathu M, Smith B D. Cardiac electrophysiologic effects of pancuronium.  Anesth Analg. 1985;  64 693-699
• 14 Clayton D. Asystole associated with vecuronium.  Br J Anesth. 1986;  58 937-938
• 15 Fox E J, Sklar G S, Hill C H. Complications related to the pressor response to endotracheal intubation.  Anesthesiology. 1977;  47 524-525
• 16 Smith M, Ray C T. Cardiac arrhythmias, increased intracranial pressure, and the autonomic nervous system.  Chest. 1971;  61 125-133
• 17 Alexander J P. Dysrhythmia and oral surgery.  Br J Anest. 1971;  43 773-778
• 18 Roth A, Angster R, Forst H. Begleitmedikation - Notwendigkeit, Nebenwirkungen und Interaktionen in der perioperativen Phase.  Anaesthesist. 1999;  48 267-283
• 19 Manz M, Mletzko R, Jung W, Lüderitz B. Electrophysiological and haemodynamic effects of lidocaine and ajmaline in the management of sustained ventricular tachycardia.  Eur Heart J. 1992;  13 1123-1128
• 20 Grant A. On the mechanismen of action of antiarrhythmic agents.  Am Heart J. 1992;  123 1130-1136
• 21 Whalley D, Wendt D, Grant A. Basic concepts in cellular cardiac electrophysiology: part II. block of the ion channels by antiarrhythmic drugs.  PACE. 1995;  18 1666-1704
• 22 McDonald T, Courtney K, Cusin W. Use-dependent block of single sodium channels by lidocaine in guinea pig ventricular mycocytes.  Biophys J. 1989;  55 1261-1277
• 23 Atlee J L. Perioperative cardiac dysrhythmias: diagnosis and management.  Anesthesiology. 1997;  86 1397-1424
• 24 Kowy P, Levine J, Herre J, Pacifico A, Lindsay B, Plumb V, Janosik D, Kopelman H, Scheinman M. Randomized, double-blind comparison of intravenous amiodaron and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardias or fibrillation.  Circulation. 1995;  92 3255-3263
• 25 Cote P, Bourassa M, Delay J, Janin A, Froment R, David P. Effects of amiodarone on cardiac and coronary hemodynamics and on myocardial metabolism in patients with coronary artery disease.  Circulation. 1978;  59 1165-1172
• 26 Gallagher J, Lieberman R, Meranze J, Spielman S, Ellison N. Amiodarone-induced complications during coronary surgery.  Anesthesiology. 1981;  55 186-188
• 27 McKinnon G, Landymore R, Marble A. Should oral amiodarone be used for sustained ventricular tachycardia in patients requiring open heart surgery.  Can J Surg. 1983;  26 355-357
• 28 Navalgund A, Alifimoff J, Jaiymec A, Bleyaert A. Amiodarone-induced sinus arrest successfully treated with ephedrine and isoproterenol.  Anesth Analg. 1986;  65 414-416
• 29 Levine J, Massumi A, Scheinman M, Winkle R, Platia E, Chilson D, Gomes A, Woosley R. Intravenous amiodarone for recurrent sustained hypotensive ventricular tachydysrhythmias.  J Am Coll Cardiol. 1996;  27 67-75
• 30 Balser J R. The rational use of intravenous amiodarone in the perioperative period.  Anesthesiology. 1997;  86 974-987
• 31 Levine J, Michael J, Guamieri T. Treatment of multifocal atrial tachycardia with verapamil.  N Engl J Med. 1985;  312 21-25
• 32 Atlee J, Hamann S, Brownlee S, Kreigh C. Conscious state comaprison of the effects of the inhalation anesthetics and diltiazem, nifedipine, or verapamil on specialized atrioventricular conduction times in spontaneously beating dog hearts.  Anesthesiology. 1988;  68 19-28
• 33 Atlee J, Bosniak Z, Yeager T. Effects of diltiazem, verapamil and inhalation anesthetics on electrophysiologic properties affecting reentrant supraventricular tachycardia in chronically instrumented dogs.  Anesthesiology. 1990;  72 889-901
• 34 Kapur P, Bloor B, Flacke W, Olewine S. Comparison of cardiovascular response to verapamil during enflurane, isoflurane or halothane anesthesia in the dog.  Anesthesiology. 1984;  61 156-160
• 35 Prystowsky E N. Proarrhythmia during drug treatment of supraventricular tachycardia: paradoxical risk of sinus rhythm and sudden death.  Am J Cardiol. 1996;  78 S8A 35-41
• 36 Freilich A, Tepper D. Adenosine and its cardiovascular effects.  Am Heart J. 1992;  123 1324-1328
• 37 Camm A, Garrat C. Adenosine and supraventricular tachycardia.  N Engl J Med. 1991;  325 1621-1629
• 38 Brodsky M, Hwang C, Hunter D, Chen P, Smith D, Ariani M, Johnston W, Alen B, Chun J, Gold C. Life-threatening alterations in heart rate after the use of adenosine in arterial flutter.  Am Heart J. 1995;  130 561-571
• 39 Seller R. The role of magnesium in digitalis toxity.  Am Heart J. 1971;  82 551-556
• 40 Zwerling H. Does exogenous magnesium suppress myocardial irritability and tachydysrhythmias in the nondigitalized patient?.  Am Heart J. 1987;  113 1046-1053
• 41 Iseri L, Freed J, Bures A. Magnesium deficiency and cardiac disorders.  Am J Med. 1975;  58 837-846
• 42 Iseri L, Chung P, Tobis J. Magnesium therapy for intractable ventricular tachyarrhythmias in normomagnesiemic patients.  West J Med. 1983;  138 823-828
• 43 Waldo A, Wells J, Cooper T, McLean W. Temporary cardiac pacing: application and techniques in the treatment of cardiac arrhythmias.  Prog Cardiovasc Dis. 1981;  23 451-474
• 44 Zoll P, Zoll R, Falk R, Clinton J, Eitel D, Antmann E. External noninvasive temporary cardiac pacing: clinical trials.  Circulation. 1985;  71 937-944
• 45 Kelly J, Royster R. Noninvasive transcutaneous pacing.  Anesth Analg. 1989;  69 229-238
• 46 Guamerio M, Furlanello F, Del Greco M, Vergara G, Inama G, Disertori M. Transesophageal atrial pacing: a first-choice technique in atrial flutter therapy.  Am Heart J. 1989;  117 1241-1251
• 47 Feeley T. Management of perioperative arrhythmias.  J Cardiothorac Vasc Anesth. 1997;  11S2 10-15
• 48 Morganroth J, Horowitz L N, Anderson J. Comparative efficacy and tolerance of esmolol to propanolol for control of supraventricular tachyharrhythmias.  Am J Cardiol. 1985;  56 33F-39F
• 49 Gray J R, Bateman T M, Czer L S. Esmolol: a new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmias.  J Am Coll cardiol. 1985;  5 1451-1456
• 50 Hill G A, Owens S D. Esmolol in the treatment of multifocal atrial tachycardia.  Chest. 1992;  101 1726-1728
• 51 Dimarco J P, Sellers T D, Berne T D. Adenosine: Electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia.  Circulation. 1983;  68 1254-1263
• 52 Stemp L I, Roy W L. Adenosine for the cardioversion of supraventricular tachycardia during general anaesthesia and open heart surgery.  Anesthesiology. 1992;  76 849-852
• 53 Raickenberger R L, Prystowsky E N, Heger J J. Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias.  Circulation. 1980;  62 996-999
• 54 Platia E V, Michelson E L, Porterfield J K. Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter.  Am J Cardiol. 1989;  63 925-929
• 55 Das G, Ferris J. Esmolol in the treatment of supraventricular tachyarrhythmias.  Can J Cardiol. 1988;  4 177-180
• 56 Sung R, Tan H, Karagounis L, Hanyok J, Falk R, Platia E, Das G, Hardy S. Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study.  Am Heart J. 1995;  129 739-748
• 57 Haldemann G, Schaer H. Hemodynamic effects of transient atrioventricular dissication in general anaesthesia.  Br J Anaesth. 1972;  44 159-162
• 58 Van Dantzig J M, Koster R W, Biervliet J D. Treatment with esmolol of ventricullar fibrillation unresponsive to lidocain and procainamide.  J Cardiothorac Vasc Anesth. 1991;  5 600-603